Hisashi Kawasaki Selected Research

1,3- dihydroxy- 2- hydroxymethylpropyl- 2- ammonium 2- ((R)- 3- cyclo- hexyl- 1- phenylpropyl)- 1,3- dioxo- 2,3- dihydro- 1H- isoindole- 5- carboxylate monohydrate

7/2005

JTP-27536 [(+)-1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-[(R)-3-cyclo-hexyl-1-phenylpropyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate monohydrate], a novel inhibitor of immunoglobulins and interleukin-5 with anti-inflammatory properties in mouse allergic dermatitis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisashi Kawasaki Research Topics

Disease

1	Neoplasms (Cancer) 04/2011
1	Dermatitis 07/2005

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 04/2011 - 07/2005
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2011
1	Immunoglobulin E (IgE)IBA 07/2005
1	Immunoglobulins (Immunoglobulin)IBA 07/2005
1	Prednisolone (Predate)FDA LinkGeneric 07/2005
1	Interleukin-5 (Interleukin 5)IBA 07/2005
1	Anti-Allergic Agents (Antiallergic Agents)IBA 07/2005
1	IsoindolesIBA 07/2005
1	suplatast tosilateIBA 07/2005
1	Ammonium CompoundsIBA 07/2005
1	1,3- dihydroxy- 2- hydroxymethylpropyl- 2- ammonium 2- ((R)- 3- cyclo- hexyl- 1- phenylpropyl)- 1,3- dioxo- 2,3- dihydro- 1H- isoindole- 5- carboxylate monohydrateIBA 07/2005
1	AntigensIBA 07/2005